Suppr超能文献

接受体外膜肺氧合治疗患者急性肾损伤的发生率及影响:一项荟萃分析

Incidence and Impact of Acute Kidney Injury in Patients Receiving Extracorporeal Membrane Oxygenation: A Meta-Analysis.

作者信息

Thongprayoon Charat, Cheungpasitporn Wisit, Lertjitbanjong Ploypin, Aeddula Narothama Reddy, Bathini Tarun, Watthanasuntorn Kanramon, Srivali Narat, Mao Michael A, Kashani Kianoush

机构信息

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.

Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.

出版信息

J Clin Med. 2019 Jul 5;8(7):981. doi: 10.3390/jcm8070981.

Abstract

BACKGROUND

Although acute kidney injury (AKI) is a frequent complication in patients receiving extracorporeal membrane oxygenation (ECMO), the incidence and impact of AKI on mortality among patients on ECMO remain unclear. We conducted this systematic review to summarize the incidence and impact of AKI on mortality risk among adult patients on ECMO.

METHODS

A literature search was performed using EMBASE, Ovid MEDLINE, and Cochrane Databases from inception until March 2019 to identify studies assessing the incidence of AKI (using a standard AKI definition), severe AKI requiring renal replacement therapy (RRT), and the impact of AKI among adult patients on ECMO. Effect estimates from the individual studies were obtained and combined utilizing random-effects, generic inverse variance method of DerSimonian-Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42018103527).

RESULTS

41 cohort studies with a total of 10,282 adult patients receiving ECMO were enrolled. Overall, the pooled estimated incidence of AKI and severe AKI requiring RRT were 62.8% (95%CI: 52.1%-72.4%) and 44.9% (95%CI: 40.8%-49.0%), respectively. Meta-regression showed that the year of study did not significantly affect the incidence of AKI ( = 0.67) or AKI requiring RRT ( = 0.83). The pooled odds ratio (OR) of hospital mortality among patients receiving ECMO with AKI on RRT was 3.73 (95% CI, 2.87-4.85). When the analysis was limited to studies with confounder-adjusted analysis, increased hospital mortality remained significant among patients receiving ECMO with AKI requiring RRT with pooled OR of 3.32 (95% CI, 2.21-4.99). There was no publication bias as evaluated by the funnel plot and Egger's regression asymmetry test with = 0.62 and = 0.17 for the incidence of AKI and severe AKI requiring RRT, respectively.

CONCLUSION

Among patients receiving ECMO, the incidence rates of AKI and severe AKI requiring RRT are high, which has not changed over time. Patients who develop AKI requiring RRT while on ECMO carry 3.7-fold higher hospital mortality.

摘要

背景

尽管急性肾损伤(AKI)是接受体外膜肺氧合(ECMO)治疗患者的常见并发症,但AKI在接受ECMO治疗患者中的发病率及其对死亡率的影响仍不明确。我们进行了这项系统评价,以总结AKI在接受ECMO治疗的成年患者中的发病率及其对死亡风险的影响。

方法

使用EMBASE、Ovid MEDLINE和Cochrane数据库进行文献检索,检索时间从数据库建立至2019年3月,以确定评估AKI发病率(使用标准AKI定义)、需要肾脏替代治疗(RRT)的严重AKI以及AKI在接受ECMO治疗的成年患者中的影响的研究。获取各研究的效应估计值,并采用DerSimonian-Laird随机效应、通用逆方差法进行合并。本系统评价的方案已在PROSPERO注册(编号CRD42018103527)。

结果

纳入了41项队列研究,共有10282例接受ECMO治疗的成年患者。总体而言,AKI以及需要RRT的严重AKI的合并估计发病率分别为62.8%(95%CI:52.1%-72.4%)和44.9%(95%CI:40.8%-49.0%)。Meta回归显示,研究年份对AKI发病率(P = 0.67)或需要RRT的AKI发病率(P = 0.83)无显著影响。接受ECMO且发生AKI并接受RRT的患者院内死亡的合并比值比(OR)为3.73(95%CI,2.87-4.85)。当分析限于进行了混杂因素调整分析的研究时,接受ECMO且发生需要RRT的AKI的患者院内死亡率仍显著升高,合并OR为3.32(95%CI,2.21-4.99)。通过漏斗图和Egger回归不对称检验评估,未发现发表偏倚,AKI和需要RRT的严重AKI发病率的检验P值分别为0.62和0.17。

结论

在接受ECMO治疗的患者中,AKI以及需要RRT的严重AKI的发病率较高,且未随时间变化。在接受ECMO治疗期间发生需要RRT的AKI的患者院内死亡率高出3.7倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/356d/6678289/170f8cfa57e9/jcm-08-00981-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验